€1 in, €5.67 out: How spending on medicines pays back in Europe’s health and economic future

EU PERSPECTIVES - Europe's spending on innovative medicines buys more than health. A new report shows that every euro returns more than five times in economic value. Newer treatments help people live longer, stay in work and spend less time in hospital. Yet health systems still often see medicines first as a cost to cut, not an investment to capture, the pharmaceutical industry argues. Read more

Without the pharmaceutical industry, the EU's €133 billion trade surplus would turn into a €93 billion deficit, says the industry / Picture: Unsplash